{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:00:34Z","timestamp":1793714434569,"version":"4.6.1"},"reference-count":120,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K08DK109116"],"award-info":[{"award-number":["K08DK109116"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2019087"],"award-info":[{"award-number":["2019087"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","award":["U070002"],"award-info":[{"award-number":["U070002"]}],"id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008269","name":"Michigan Institute for Clinical & Health Research","doi-asserted-by":"crossref","award":["R01DK115392"],"award-info":[{"award-number":["R01DK115392"]}],"id":[{"id":"10.13039\/100008269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Several studies over the past 3 decades document a higher prevalence of primary aldosteronism (PA) among hypertensive patients than generally presumed. PA exists as a spectrum from mild to severe aldosterone excess. Although a variety of PA subtypes exist, the 2 most common are aldosterone-producing adenomas (APAs) and bilateral hyperaldosteronism (BHA). The distinction is important, because APA\u2014and other subtypes, with aldosterone production mostly from 1 adrenal\u2014can be cured surgically, and BHA should be treated medically with mineralocorticoid-receptor antagonists (MRAs). The major shortcomings in the tailored management of patients with possible PA are the low rates of screening for case identification and the expensive and technically challenging imaging and interventional procedures required to distinguish APA from BHA, especially adrenal vein sampling (AVS). When AVS identifies an APA and allows the patient to be cured surgically, the procedure is of great value. In contrast, the patient with BHA is treated with MRA whether AVS is performed or not. Consequently, it is prudent to gauge how likely it is to benefit from imaging and AVS in each case prior to embarking on these studies. The explosion of information about PA in the past decade, including predictors of APA and of surgical benefit, are useful in limiting the evaluation for some patients with a positive PA screening test. This article will review our suggestions for approaching these patients in a pragmatic style, recognizing the limitations to even the best resources and facilities.<\/jats:p>","DOI":"10.1210\/clinem\/dgaa952","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T14:30:18Z","timestamp":1609425018000},"page":"1195-1208","source":"Crossref","is-referenced-by-count":45,"title":["Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling"],"prefix":"10.1210","volume":"106","author":[{"given":"Adina F","family":"Turcu","sequence":"first","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6815-6181","authenticated-orcid":false,"given":"Richard","family":"Auchus","sequence":"additional","affiliation":[{"name":"Division of Metabolism, Endocrinology, and Diabetes, Ann Arbor, Michigan, USA"},{"name":"Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA"},{"name":"Ann Arbor Veterans Affairs Hospital, Ann Arbor, Michigan, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"issue":"10","key":"2021032609300749700_CIT0001","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1210\/jc.2010-0823","article-title":"Reversible sympathetic overactivity in hypertensive patients with primary aldosteronism","volume":"95","author":"Kontak","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021032609300749700_CIT0002","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: a systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021032609300749700_CIT0003","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension."},{"issue":"9628","key":"2021032609300749700_CIT0004","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet."},{"issue":"4","key":"2021032609300749700_CIT0005","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCULATIONAHA.117.028201","article-title":"Age-related autonomous aldosteronism","volume":"136","author":"Nanba","year":"2017","journal-title":"Circulation."},{"issue":"3","key":"2021032609300749700_CIT0006","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0031-1295438","article-title":"Prevalence of primary aldosteronism in patient\u2019s cohorts and in population-based studies\u2013a review of the current literature","volume":"44","author":"Hannemann","year":"2012","journal-title":"Horm Metab Res."},{"issue":"14","key":"2021032609300749700_CIT0007","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"2021032609300749700_CIT0008","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021032609300749700_CIT0009","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0010","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"2021032609300749700_CIT0011","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1530\/EJE-12-0631","article-title":"Effectiveness of eplerenone or spironolactone treatment in preserving renal function in primary aldosteronism","volume":"168","author":"Fourkiotis","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021032609300749700_CIT0012","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1210\/jc.2013-2180","article-title":"Predictors of decreasing glomerular filtration rate and prevalence of chronic kidney disease after treatment of primary aldosteronism: renal outcome of 213 cases","volume":"99","author":"Iwakura","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021032609300749700_CIT0013","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"2021032609300749700_CIT0014","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension."},{"issue":"3","key":"2021032609300749700_CIT0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension."},{"issue":"8","key":"2021032609300749700_CIT0016","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol."},{"issue":"1","key":"2021032609300749700_CIT0017","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","article-title":"Mineralocorticoid receptor blockade in the protection of target organ damage","volume":"4","author":"Mulatero","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem."},{"issue":"8","key":"2021032609300749700_CIT0018","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrneph.2013.110","article-title":"Contribution of aldosterone to cardiovascular and renal inflammation and fibrosis","volume":"9","author":"Brown","year":"2013","journal-title":"Nat Rev Nephrol."},{"issue":"12","key":"2021032609300749700_CIT0019","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/01.hjh.0000251908.93298.a0","article-title":"QT interval in patients with primary aldosteronism and low-renin essential hypertension","volume":"24","author":"Maule","year":"2006","journal-title":"J Hypertens."},{"issue":"2","key":"2021032609300749700_CIT0020","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab."},{"issue":"23","key":"2021032609300749700_CIT0021","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation."},{"issue":"2","key":"2021032609300749700_CIT0022","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/01.HYP.0000230444.01215.6a","article-title":"Renal damage in primary aldosteronism: results of the PAPY Study","volume":"48","author":"Rossi","year":"2006","journal-title":"Hypertension."},{"issue":"2","key":"2021032609300749700_CIT0023","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin","volume":"41","author":"Koz\u00e0kov\u00e0","year":"2003","journal-title":"Hypertension."},{"issue":"6","key":"2021032609300749700_CIT0024","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCIMAGING.112.974576","article-title":"Demonstration of blood pressure-independent noninfarct myocardial fibrosis in primary aldosteronism: a cardiac magnetic resonance imaging study","volume":"5","author":"Freel","year":"2012","journal-title":"Circ Cardiovasc Imaging."},{"issue":"10","key":"2021032609300749700_CIT0025","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1097\/HJH.0b013e32833d0177","article-title":"Increased levels of oxidative stress, subclinical inflammation, and myocardial fibrosis markers in primary aldosteronism patients","volume":"28","author":"Stehr","year":"2010","journal-title":"J Hypertens."},{"issue":"12","key":"2021032609300749700_CIT0026","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021032609300749700_CIT0027","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0028","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis."},{"issue":"1-2","key":"2021032609300749700_CIT0029","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol."},{"issue":"7","key":"2021032609300749700_CIT0030","doi-asserted-by":"crossref","first-page":"E1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"2021032609300749700_CIT0031","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol."},{"issue":"3","key":"2021032609300749700_CIT0032","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1210\/clinem\/dgz235","article-title":"Histological characterization of aldosterone-producing adrenocortical adenomas with different somatic mutations","volume":"105","author":"Ono","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021032609300749700_CIT0033","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white Americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021032609300749700_CIT0034","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension."},{"issue":"4","key":"2021032609300749700_CIT0035","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension."},{"issue":"5","key":"2021032609300749700_CIT0036","doi-asserted-by":"crossref","first-page":"K37","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur J Endocrinol."},{"issue":"11","key":"2021032609300749700_CIT0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-019-0337-9","article-title":"Genetic causes of primary aldosteronism","volume":"51","author":"Seidel","year":"2019","journal-title":"Exp Mol Med."},{"issue":"3","key":"2021032609300749700_CIT0038","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension."},{"issue":"3","key":"2021032609300749700_CIT0039","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/HYPERTENSIONAHA.119.12935","article-title":"Primary aldosteronism","volume":"74","author":"Funder","year":"2019","journal-title":"Hypertension."},{"issue":"4","key":"2021032609300749700_CIT0040","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension."},{"issue":"2","key":"2021032609300749700_CIT0041","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021032609300749700_CIT0042","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1507\/endocrj.EJ15-0362","article-title":"Eplerenone improves carotid intima-media thickness (IMT) in patients with primary aldosteronism","volume":"63","author":"Matsuda","year":"2016","journal-title":"Endocr J."},{"issue":"9","key":"2021032609300749700_CIT0043","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021032609300749700_CIT0044","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg."},{"issue":"6","key":"2021032609300749700_CIT0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/cen.13442","article-title":"Discordance between imaging and immunohistochemistry in unilateral primary aldosteronism","volume":"87","author":"Nanba","year":"2017","journal-title":"Clin Endocrinol."},{"issue":"12","key":"2021032609300749700_CIT0046","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1046\/j.1365-2168.2002.02261.x","article-title":"Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism","volume":"89","author":"Sywak","year":"2002","journal-title":"Br J Surg."},{"issue":"1","key":"2021032609300749700_CIT0047","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2017-01442","article-title":"Quality of life in primary aldosteronism: a comparative effectiveness study of adrenalectomy and medical treatment","volume":"103","author":"Velema","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"key":"2021032609300749700_CIT0048","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/IBPC.S13783","article-title":"Mineralocorticoid receptor antagonists: emerging roles in cardiovascular medicine","volume":"6","author":"Funder","year":"2013","journal-title":"Integr Blood Press Control."},{"issue":"8","key":"2021032609300749700_CIT0049","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0895-7061(02)02957-6","article-title":"Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension","volume":"15","author":"Weinberger","year":"2002","journal-title":"Am J Hypertens."},{"issue":"4","key":"2021032609300749700_CIT0050","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0051","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1161\/HYPERTENSIONAHA.113.02097","article-title":"An expert consensus statement on use of adrenal vein sampling for the subtyping of primary aldosteronism","volume":"63","author":"Rossi","year":"2014","journal-title":"Hypertension."},{"issue":"12","key":"2021032609300749700_CIT0052","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"7","key":"2021032609300749700_CIT0053","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/HJH.0000000000002348","article-title":"Aldosterone-potassium ratio predicts primary aldosteronism subtype","volume":"38","author":"Puar","year":"2020","journal-title":"J Hypertens."},{"issue":"4","key":"2021032609300749700_CIT0054","first-page":"1182","article-title":"Histopathological classification of cross-sectional image-negative hyperaldosteronism","volume":"102","author":"Yamazaki","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021032609300749700_CIT0055","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1530\/EJE-09-0234","article-title":"Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink?","volume":"161","author":"Cawood","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"2021032609300749700_CIT0056","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"39","key":"2021032609300749700_CIT0057","doi-asserted-by":"crossref","first-page":"e4986","DOI":"10.1097\/MD.0000000000004986","article-title":"Comparison between adrenal venous sampling and computed tomography in the diagnosis of primary aldosteronism and in the guidance of adrenalectomy","volume":"95","author":"Zhu","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"8","key":"2021032609300749700_CIT0058","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1210\/jc.2013-4146","article-title":"Accuracy of adrenal imaging and adrenal venous sampling in predicting surgical cure of primary aldosteronism","volume":"99","author":"Lim","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021032609300749700_CIT0059","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med."},{"issue":"3","key":"2021032609300749700_CIT0060","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jamcollsurg.2010.05.006","article-title":"Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease","volume":"211","author":"Mathur","year":"2010","journal-title":"J Am Coll Surg."},{"issue":"5","key":"2021032609300749700_CIT0061","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/cen.13582","article-title":"Accuracy of adrenal computed tomography in predicting the unilateral subtype in young patients with hypokalaemia and elevation of aldosterone in primary aldosteronism","volume":"88","author":"Umakoshi","year":"2018","journal-title":"Clin Endocrinol."},{"issue":"10","key":"2021032609300749700_CIT0062","doi-asserted-by":"crossref","first-page":"e3628","DOI":"10.1210\/clinem\/dgaa482","article-title":"The concordance between imaging and adrenal venous sampling varies with aldosterone-driver somatic mutation","volume":"105","author":"Wannachalee","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"2021032609300749700_CIT0063","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"12","key":"2021032609300749700_CIT0064","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1055\/s-0043-120524","article-title":"The SPARTACUS trial: controversies and unresolved issues","volume":"49","author":"Beuschlein","year":"2017","journal-title":"Horm Metab Res."},{"issue":"7","key":"2021032609300749700_CIT0065","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1210\/jc.2008-2803","article-title":"Role of unilateral adrenalectomy in bilateral primary aldosteronism: a 22-year single center experience","volume":"94","author":"Sukor","year":"2009","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021032609300749700_CIT0066","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1161\/HYPERTENSIONAHA.118.11382","article-title":"Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism","volume":"72","author":"Williams","year":"2018","journal-title":"Hypertension."},{"issue":"11","key":"2021032609300749700_CIT0067","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1097\/RLU.0b013e3181f4a16d","article-title":"Adrenal cortical imaging with I-131 NP-59 SPECT-CT","volume":"35","author":"Wong","year":"2010","journal-title":"Clin Nucl Med."},{"issue":"1","key":"2021032609300749700_CIT0068","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1210\/jc.2011-1537","article-title":"Evaluation of the sensitivity and specificity of 11C-metomidate positron emission tomography (PET)-CT for lateralizing aldosterone secretion by Conn\u2019s adenomas","volume":"97","author":"Burton","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021032609300749700_CIT0069","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR (CXC Chemokine Receptor Type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","author":"Heinze","year":"2018","journal-title":"Hypertension."},{"issue":"12","key":"2021032609300749700_CIT0070","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1210\/jc.2014-2788","article-title":"Outcome of adrenal vein sampling performed during concurrent mineralocorticoid receptor antagonist therapy","volume":"99","author":"Haase","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021032609300749700_CIT0071","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/jc.2018-01299","article-title":"Adrenal vein sampling lateralization despite mineralocorticoid receptor antagonists exposure in primary aldosteronism","volume":"104","author":"Nanba","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2021032609300749700_CIT0072","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1148\/rg.25si055514","article-title":"Adrenal vein sampling: how to make it quick, easy, and successful","volume":"25","author":"Daunt","year":"2005","journal-title":"Radiographics."},{"issue":"1","key":"2021032609300749700_CIT0073","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2265.2008.03450.x","article-title":"What are the keys to successful adrenal venous sampling (AVS) in patients with primary aldosteronism?","volume":"70","author":"Young","year":"2009","journal-title":"Clin Endocrinol."},{"issue":"2","key":"2021032609300749700_CIT0074","first-page":"89","article-title":"Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures","volume":"24","author":"Jakobsson","year":"2018","journal-title":"Diagn Interv Radiol."},{"issue":"2","key":"2021032609300749700_CIT0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/SLA.0b013e3181961d77","article-title":"Rapid cortisol assays improve the success rate of adrenal vein sampling for primary aldosteronism","volume":"249","author":"Auchus","year":"2009","journal-title":"Ann Surg."},{"issue":"2","key":"2021032609300749700_CIT0076","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1530\/EJE-11-0287","article-title":"Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates","volume":"165","author":"Betz","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021032609300749700_CIT0077","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021032609300749700_CIT0078","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/HYPERTENSIONAHA.119.14341","article-title":"Precise mapping of intra-adrenal aldosterone activities provides a novel surgical strategy for primary aldosteronism","volume":"76","author":"Kitamoto","year":"2020","journal-title":"Hypertension."},{"issue":"4","key":"2021032609300749700_CIT0079","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1210\/jc.2015-3915","article-title":"Basal and post-ACTH aldosterone and its ratios are useful during adrenal vein sampling in primary aldosteronism","volume":"101","author":"El Ghorayeb","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021032609300749700_CIT0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-20-0254","article-title":"Basal contralateral aldosterone suppression is rare in lateralized primary aldosteronism","volume":"183","author":"Desrochers","year":"2020","journal-title":"Eur J Endocrinol."},{"issue":"15","key":"2021032609300749700_CIT0081","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.clinbiochem.2013.04.004","article-title":"Adrenal vein sampling: substantial need for technical improvement at regional referral centres","volume":"46","author":"Elliott","year":"2013","journal-title":"Clin Biochem."},{"issue":"4","key":"2021032609300749700_CIT0082","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/HYPERTENSIONAHA.111.189548","article-title":"Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism","volume":"59","author":"Monticone","year":"2012","journal-title":"Hypertension."},{"issue":"5","key":"2021032609300749700_CIT0083","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/HJH.0b013e3282f9e66a","article-title":"Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation","volume":"26","author":"Rossi","year":"2008","journal-title":"J Hypertens."},{"issue":"5","key":"2021032609300749700_CIT0084","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/HYPERTENSIONAHA.108.128553","article-title":"Adrenocorticotropic hormone stimulation during adrenal vein sampling for identifying surgically curable subtypes of primary aldosteronism: comparison of 3 different protocols","volume":"53","author":"Seccia","year":"2009","journal-title":"Hypertension."},{"issue":"2","key":"2021032609300749700_CIT0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.hjh.0000202818.10459.96","article-title":"Dynamic testing with high-dose adrenocorticotrophic hormone does not improve lateralization of aldosterone oversecretion in primary aldosteronism patients","volume":"24","author":"Rossi","year":"2006","journal-title":"J Hypertens."},{"issue":"5","key":"2021032609300749700_CIT0086","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/HJH.0000000000001964","article-title":"Impact of adrenocorticotropic hormone stimulation during adrenal venous sampling on outcomes of primary aldosteronism","volume":"37","author":"Takeda","year":"2019","journal-title":"J Hypertens."},{"issue":"5","key":"2021032609300749700_CIT0087","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cen.13110","article-title":"Does ACTH improve the diagnostic performance of adrenal vein sampling for subtyping primary aldosteronism?","volume":"85","author":"Wolley","year":"2016","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"2021032609300749700_CIT0088","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery."},{"key":"2021032609300749700_CIT0089","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"8","key":"2021032609300749700_CIT0090","doi-asserted-by":"crossref","first-page":"e93136","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight."},{"issue":"11","key":"2021032609300749700_CIT0091","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jc.2019-00996","article-title":"Adrenal insufficiency after unilateral adrenalectomy in primary aldosteronism: long-term outcome and clinical impact","volume":"104","author":"Heinrich","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021032609300749700_CIT0092","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021032609300749700_CIT0093","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1210\/clinem\/dgaa105","article-title":"Accuracy of laboratory tests for the diagnosis of Cushing syndrome","volume":"105","author":"Galm","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021032609300749700_CIT0094","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021032609300749700_CIT0095","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2013-3527","article-title":"Long-term follow-up in adrenal incidentalomas: an Italian multicenter study","volume":"99","author":"Morelli","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021032609300749700_CIT0096","doi-asserted-by":"crossref","first-page":"e3776","DOI":"10.1210\/clinem\/dgaa519","article-title":"Low grade cortisol co-secretion has limited impact on ACTH-stimulated AVS parameters in primary aldosteronism","volume":"105","author":"O\u2019Toole","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021032609300749700_CIT0097","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/HYPERTENSIONAHA.113.01601","article-title":"Plasma metanephrine for assessing the selectivity of adrenal venous sampling","volume":"62","author":"Dekkers","year":"2013","journal-title":"Hypertension."},{"issue":"3","key":"2021032609300749700_CIT0098","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin Chem."},{"key":"2021032609300749700_CIT0099","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.steroids.2018.04.002","article-title":"Adrenal androgen measurement for assessing the selectivity of adrenal venous sampling in primary aldosteronism","volume":"134","author":"Li","year":"2018","journal-title":"Steroids."},{"issue":"1","key":"2021032609300749700_CIT0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive analysis of steroid biomarkers for guiding primary aldosteronism subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0101","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.surg.2015.06.048","article-title":"Diagnostic utility of data from adrenal venous sampling for primary aldosteronism despite failed cannulation of the right adrenal vein","volume":"159","author":"Pasternak","year":"2016","journal-title":"Surgery."},{"issue":"4","key":"2021032609300749700_CIT0102","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.surg.2017.10.012","article-title":"Primary aldosteronism: making sense of partial data sets from failed adrenal venous sampling-suppression of adrenal aldosterone production can be used in clinical decision making","volume":"163","author":"Strajina","year":"2018","journal-title":"Surgery."},{"issue":"2","key":"2021032609300749700_CIT0103","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/HYPERTENSIONAHA.117.09415","article-title":"Androstenedione and 17-\u03b1-hydroxyprogesterone are better indicators of adrenal vein sampling selectivity than cortisol","volume":"70","author":"Ceolotto","year":"2017","journal-title":"Hypertension."},{"issue":"7","key":"2021032609300749700_CIT0104","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1210\/jc.2006-2631","article-title":"Measurement of 18-hydroxycorticosterone during adrenal vein sampling for primary aldosteronism","volume":"92","author":"Auchus","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2021032609300749700_CIT0105","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2010-2785","article-title":"18-oxocortisol measurement in adrenal vein sampling as a biomarker for subclassifying primary aldosteronism","volume":"96","author":"Nakamura","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021032609300749700_CIT0106","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-18-0328","article-title":"Radiation exposure of adrenal vein sampling: a German Multicenter Study","volume":"179","author":"Fuss","year":"2018","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"2021032609300749700_CIT0107","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/HYPERTENSIONAHA.110.168484","article-title":"Adrenal venous sampling: evaluation of the German Conn\u2019s registry","volume":"57","author":"Vonend","year":"2011","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0108","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/HYPERTENSIONAHA.115.06305","article-title":"Clinical management and outcomes of adrenal hemorrhage following adrenal vein sampling in primary aldosteronism","volume":"67","author":"Monticone","year":"2016","journal-title":"Hypertension."},{"issue":"5","key":"2021032609300749700_CIT0109","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/HYPERTENSIONAHA.115.06607","article-title":"Adrenal venous sampling in patients with positive screening but negative confirmatory testing for primary aldosteronism","volume":"67","author":"Umakoshi","year":"2016","journal-title":"Hypertension."},{"issue":"10","key":"2021032609300749700_CIT0110","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1210\/jc.2012-1917","article-title":"A clinical prediction score to diagnose unilateral primary aldosteronism","volume":"97","author":"K\u00fcpers","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"2021032609300749700_CIT0111","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/HJH.0000000000001855","article-title":"Development and validation of subtype prediction scores for the workup of primary aldosteronism","volume":"36","author":"Kobayashi","year":"2018","journal-title":"J Hypertens."},{"key":"2021032609300749700_CIT0112","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa379","article-title":"Development and validation of prediction models for subtype diagnosis of patients with primary aldosteronism","author":"Burrello","year":"2020","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021032609300749700_CIT0113","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"2021032609300749700_CIT0114","doi-asserted-by":"crossref","first-page":"258","DOI":"10.7326\/0003-4819-135-4-200108210-00010","article-title":"Primary aldosteronism: factors associated with normalization of blood pressure after surgery","volume":"135","author":"Sawka","year":"2001","journal-title":"Ann Intern Med."},{"issue":"3","key":"2021032609300749700_CIT0115","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/SLA.0b013e318165c075","article-title":"The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma","volume":"247","author":"Zarnegar","year":"2008","journal-title":"Ann Surg."},{"issue":"2","key":"2021032609300749700_CIT0116","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","article-title":"Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension","volume":"131","author":"Pratt-Ubunama","year":"2007","journal-title":"Chest."},{"issue":"6","key":"2021032609300749700_CIT0117","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/HYPERTENSIONAHA.119.13833","article-title":"Primary aldosteronism and obstructive sleep apnea: a cross-sectional multi-ethnic study","volume":"74","author":"Buffolo","year":"2019","journal-title":"Hypertension."},{"issue":"3","key":"2021032609300749700_CIT0118","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1210\/jc.2015-3431","article-title":"A novel CYP11B2-specific imaging agent for detection of unilateral subtypes of primary aldosteronism","volume":"101","author":"Abe","year":"2016","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021032609300749700_CIT0119","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension."},{"issue":"1","key":"2021032609300749700_CIT0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-specific steroid profiles associated with aldosterone-producing adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa952\/35922546\/dgaa952.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/4\/1195\/36735625\/dgaa952.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/106\/4\/1195\/36735625\/dgaa952.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T09:33:10Z","timestamp":1616751190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/4\/1195\/6056487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":120,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,12,31]]},"published-print":{"date-parts":[[2021,3,25]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa952","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,4,1]]},"published":{"date-parts":[[2020,12,31]]}}}